Relationship between CCL5 and transforming growth factor-β1 (TGFβ1) in breast cancer

European Journal of Cancer

Volumn 47, Issue 11, 2011, Pages 1669-1675

  Hartmann, M C ^a   Dwyer, R M ^a   Costello, M ^a   Potter, S M ^a   Curran, C ^a   Hennessy, E ^a   Newell, J ^a   Griffin, D G ^b   Kerin, M J ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

Breast cancer; CCL5; Menstrual hormones; Microenvironment; Stromal epithelial interaction; TGF 1; Tumour

Indexed keywords

CHEMOKINE RECEPTOR CCR5; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PROGESTERONE; RANTES; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREMENOPAUSE; PRIORITY JOURNAL; STROMA CELL; TUMOR MICROENVIRONMENT;

AGED; BREAST NEOPLASMS; CHEMOKINE CCL5; CHEMOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUTEINIZING HORMONE; MIDDLE AGED; MODELS, BIOLOGICAL; PROGESTERONE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79959978238     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.05.001     Document Type: Article

References (29)

1. F. Balkwill, and A. Mantovani Inflammation and Cancer: back to Virchow? Lancet 357 9255 2001 539 545 (Pubitemid 32173595)
2. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 6917 2002 860 867 (Pubitemid 36019639)
3. A.A. Maghazachi, A. Al-Aoukaty, and T.J. Schall CC chemokines induce the generation of killer cells from CD56+ cells Eur J Immunol 26 2 1996 315 319 (Pubitemid 26060235)
4. G. Soria, and A. Ben-Baruch The inflammatory chemokines CCL2 and CCL5 in breast cancer Cancer Lett 267 2 2008 271 285
5. M. Samson, P. Stordeur, and O. Labbe Molecular cloning and chromosomal mapping of a novel human gene, ChemR1, expressed in T lymphocytes and polymorphonuclear cells and encoding a putative chemokine receptor Eur J Immunol 26 12 1996 3021 3028 (Pubitemid 26411508)
6. Y. Niwa, H. Akamatsu, and H. Niwa Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer Clin Cancer Res 7 2 2001 285 289 (Pubitemid 32183031)
7. S.A. Eissa, S.A. Zaki, S.M. El-Maghraby, and D.Y. Kadry Importance of serum IL-18 and RANTES as markers for breast carcinoma progression J Egypt Natl Canc Inst 17 1 2005 51 55
8. G. Luboshits, S. Shina, and O. Kaplan Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma Cancer Res 59 18 1999 4681 4687 (Pubitemid 29428976)
9. G. Soria, N. Yaal-Hahoshen, and E. Azenshtein Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions Cytokine 44 1 2008 191 200
10. K.A. Stormes, C.A. Lemken, J.V. Lepre, M.N. Marinucci, and R.A. Kurt Inhibition of metastasis by inhibition of tumor-derived CCL5 Breast Cancer Res Treat 89 2 2005 209 212 (Pubitemid 40249055)
11. E.P. Adler, C.A. Lemken, N.S. Katchen, and R.A. Kurt A dual role for tumor-derived chemokine RANTES (CCL5) Immunol Lett 90 2-3 2003 187 194 (Pubitemid 37548476)
12. M.M. Jayasinghe, J.M. Golden, and P. Nair Tumor-derived CCL5 does not contribute to breast cancer progression Breast Cancer Res Treat 111 3 2008 511 521
13. N. Yaal-Hahoshen, S. Shina, and L. Leider-Trejo The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients Clin Cancer Res 12 15 2006 4474 4480 (Pubitemid 44297794)
14. G.E. Christodoulakos, I.V. Lambrinoudaki, and E.V. Economou Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene Atherosclerosis 193 1 2007 142 150 (Pubitemid 46776695)
15. S.R. Cummings, S. Eckert, and K.A. Krueger The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple outcomes of raloxifene evaluation Jama 281 23 1999 2189 2197 (Pubitemid 29275701)
16. V.G. Vogel, J.P. Costantino, and D.L. Wickerham Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial Jama 295 23 2006 2727 2741
17. V.S. Rao, C.E. Dyer, J.K. Jameel, P.J. Drew, and J. Greenman Potential prognostic and therapeutic roles for cytokines in breast cancer (Review) Oncol Rep 15 1 2006 179 185
18. D. Padua, and J. Massague Roles of TGFbeta in metastasis Cell Res 19 1 2009 89 102
19. A. Lebrecht, C. Grimm, and G. Euller Transforming growth factor beta 1 serum levels in patients with preinvasive and invasive lesions of the breast Int J Biol Markers 19 3 2004 236 239 (Pubitemid 39406246)
20. M.H. Barcellos-Hoff, and R.J. Akhurst Transforming growth factor-beta in breast cancer: too much, too late Breast Cancer Res 11 1 2009 202
21. F.M. Kong, M.S. Anscher, and T. Murase Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor Ann Surg 222 2 1995 155 162
22. A.M. Grau, W. Wen, and D.S. Ramroopsingh Circulating transforming growth factor-beta-1 and breast cancer prognosis: results from the Shanghai Breast Cancer Study Breast Cancer Res Treat 112 2 2008 335 341
23. R.E. McNeill, N. Miller, and M.J. Kerin Evaluation and validation of candidate endogenous control genes for real-time quantitative PCR studies of breast cancer BMC Mol Biol 8 2007 107
24. S.M. Potter, R.M. Dwyer, and C.E. Curran Systemic chemokine levels in breast cancer patients and their relationship with circulating menstrual hormones Breast Cancer Res Treat 115 2 2009 279 287
25. K. Heer, H. Kumar, and V. Speirs Vascular endothelial growth factor in premenopausal women - indicator of the best time for breast cancer surgery? Br J Cancer 78 9 1998 1203 1207 (Pubitemid 28479152)
26. N. Cheng, N.A. Bhowmick, and A. Chytil Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks Oncogene 24 32 2005 5053 5068 (Pubitemid 41129083)
27. A.E. Karnoub, A.B. Dash, and A.P. Vo Mesenchymal stem cells within tumour stroma promote breast cancer metastasis Nature 449 7162 2007 557 563 (Pubitemid 47525152)
28. E. Forrester, A. Chytil, and B. Bierie Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis Cancer Res 65 6 2005 2296 2302 (Pubitemid 40490139)
29. S. Pinilla, E. Alt, and F.J. Abdul Khalek Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion Cancer Lett 284 1 2009 80 85